Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Athenex Inc (NQ: ATNX )

13.94 USD +0.55 (+4.11%)
Official Closing Price Updated: 7:47 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athenex Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CEO Dr. Johnson Lau Recuperating from COVID at Home
From GlobeNewswire News Releases
Implied XBI Analyst Target Price: $202
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of March 19th Options Trading For Athenex (ATNX)
Investors in Athenex Inc (ATNX) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATNX options chain... 
Tags Stocks
From Market News Video
CEO Dr. Johnson Lau Contracts COVID-19
From GlobeNewswire News Releases
ATNX Makes Bullish Cross Above Critical Moving Average
In trading on Thursday, shares of Athenex Inc (ATNX) crossed above their 200 day moving average of $11.52, changing hands as high as $11.78 per share. Athenex Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Athenex to Present at the 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
First Week of February 2021 Options Trading For Athenex (ATNX)
Investors in Athenex Inc (ATNX) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATNX options chain... 
Tags Stocks
From Market News Video
Analysts Predict 28% Gains Ahead For The Holdings of LABU
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis
-- Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp 
From PR Newswire
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
From GlobeNewswire News Releases
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer
From GlobeNewswire News Releases
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TCDA RARE ASMB
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags INCY RCKT IMV
From Benzinga
Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready to Dilute Cyclophosphamide
From GlobeNewswire News Releases
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
The U.S. Food and Drug Administration'sapproval machinery churned out a lot of disappointments in November. Most of the ... 
Tags MYOV SNY BMY
From Benzinga
Interesting ATNX Put And Call Options For July 2021
Investors in Athenex Inc (ATNX) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
From GlobeNewswire News Releases
Analysts Expect 56% Upside For XBI
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MYOK IOVA HOLX
From Benzinga
Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags BIIB TBPH CTMX
From Benzinga
Investors Snag ATNX Even Cheaper Than Its Secondary Stock Offering
Looking back to 48 days ago, Athenex Inc (ATNX) priced a 10,000,000 share secondary stock offering at $11.00 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For October 26, 2020
Upgrades Wedbush upgraded the previous rating for Huntington Bancshares Inc (NASDAQ: HBAN) from Neutral to Outperform. Huntington ... 
Tags CCI CHKP Upgrades
From Benzinga
Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020
From GlobeNewswire News Releases
Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell Therapy in Taiwan
From GlobeNewswire News Releases
Athenex Oncology launches Your Guide to Facing Metastatic Breast Cancer, a first-of-its-kind self-care resource for people living with metastatic breast cancer (MBC)
Guide offers evidence-based recommendations for increasing resilience, reducing stress, maintaining proper nutrition, and other tips to facilitate managing MBC 
From PR Newswire
TUSA's Underlying Holdings Could Mean 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
ATNX Makes Notable Cross Below Critical Moving Average
In trading on Thursday, shares of Athenex Inc (ATNX) crossed below their 200 day moving average of $11.98, changing hands as low as $11.80 per share. Athenex Inc shares are currently trading off about... 
Tags Stocks
From Market News Video
Athenex Announces FDA Allowance of IND Application for TCRT-ESO-A2, a TCR-T Cell Therapy
Athenex’s first T cell therapy product cleared to advance to the first stage of clinical development in the U.S. 
From GlobeNewswire News Releases
Athenex Gets RS Rating Upgrade
Athenex shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.